DESIGN AND SYNTHESIS OF SOME SUBSTITUTED ACRIDINE DERIVATIVES OF ANTICIPATED ANTITUMOR ACTIVITY | ||||
Bulletin of Pharmaceutical Sciences Assiut University | ||||
Article 10, Volume 30, Issue 2, December 2007, Page 213-234 PDF (449.89 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/bfsa.2007.64201 | ||||
View on SCiNiTO | ||||
Authors | ||||
S. M. El-Moghazy Aly1; D. E. Abdel Rahman1; S. E. -S. Abbas1; M. A. - A. Mohammed1; A. H. Amin2 | ||||
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo-11562, Egypt | ||||
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Beni Sueif University, Egypt | ||||
Abstract | ||||
Four series of new acridine derivatives of anticipated antitumor activity have been designed and synthesized. The first series belongs to 4-substituted phenylhydrazinocarbonylmethyl 9-oxo- 9,10-dihydroacridine-4-carboxylate 10a-h. The second series consists of phenylhydrazinocarbonylmethyl 9-(4-substituted phenyl)aminoacridine-4-carboxylate 12a-k, while the third series comprises 4-substituted phenylcarbamoylmethyl 9-(4-substituted phenyl)aminoacridine-4-carboxylate 15a-k. The fourth one belongs to phenylcarbamoylmethyl 9-(4-substituted phenyl)aminoacridine- 4- carboxylate 17a-j. The chemical structure of synthesized compounds was elucidated by spectral data and elemental analysis. Seventeen selected compounds (10a, 10g, 10h, 12a, 12d, 12g, 12h, 12k, 15a, 15c, 15g, 15h, 15k, 17a, 17f, 17g and 17j) were tested against breast cancer cell line (MCF7) and eight compounds (12g, 12h, 12k, 15g, 15h, 17f, 17g, 17j) were found to exhibit significant antitumor activity | ||||
Statistics Article View: 129 PDF Download: 263 |
||||